| 000 | 01733 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516221401.0 | ||
| 264 | 0 | _c20150330 | |
| 008 | 201503s 0 0 eng d | ||
| 022 | _a1791-244X | ||
| 024 | 7 |
_a10.3892/ijmm.2014.1819 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSu, Yan | |
| 245 | 0 | 0 |
_aThe effects of MIBG on the invasive properties of HepG2 hepatocellular carcinoma cells. _h[electronic resource] |
| 260 |
_bInternational journal of molecular medicine _cSep 2014 |
||
| 300 |
_a842-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a3-Iodobenzylguanidine _xpharmacology |
| 650 | 0 | 4 |
_aADP Ribose Transferases _xgenetics |
| 650 | 0 | 4 |
_aAntigens, CD _xgenetics |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xgenetics |
| 650 | 0 | 4 |
_aCell Movement _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorescent Antibody Technique |
| 650 | 0 | 4 |
_aFocal Adhesion Protein-Tyrosine Kinases _xmetabolism |
| 650 | 0 | 4 |
_aGPI-Linked Proteins _xgenetics |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aIntegrin alpha Chains _xgenetics |
| 650 | 0 | 4 |
_aLiver Neoplasms _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeoplasm Invasiveness |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
| 650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xmetabolism |
| 700 | 1 | _aGuan, Xiao-Qin | |
| 700 | 1 | _aLiu, Feng-Qiu | |
| 700 | 1 | _aWang, Ya-Lan | |
| 773 | 0 |
_tInternational journal of molecular medicine _gvol. 34 _gno. 3 _gp. 842-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3892/ijmm.2014.1819 _zAvailable from publisher's website |
| 999 |
_c23957763 _d23957763 |
||